Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Françoise Haramburu

Showing results (31-40 of 67) with videos related to

Pageof 7
Sort By:
Fundamental & Clinical Pharmacology|January 10, 2018
Adverse drug reactions of analgesic medicines: analysis of the Romanian pharmacovigilance databaseIrina Cazacu, Roxana Stroe, Roxana Dondera, et al.
Drug Safety|July 1, 2017
Impact of Medicine Withdrawal on Reporting of Adverse Events Involving Therapeutic Alternatives: A Study from the French Spontaneous Reporting DatabaseCécile Pageot, Julien Bezin, Andy Smith, et al.
Therapie|June 3, 2005
[Antidepressant adverse effects in the elderly: analysis of spontaneous reports in France]Mathilde Daurel-Receveur, Ghada Miremont-Salamé, Annie Fourrier, et al.
Drug Safety|October 8, 2010
Comparison of three methods (consensual expert judgement, algorithmic and probabilistic approaches) of causality assessment of adverse drug reactions: an assessment using reports made to a French pharmacovigilance centreHélène Théophile, Yannick Arimone, Ghada Miremont-Salamé, et al.
British Journal of Clinical Pharmacology|August 23, 2007
Inter-expert agreement of seven criteria in causality assessment of adverse drug reactionsYannick Arimone, Ghada Miremont-Salamé, Françoise Haramburu, et al.
Pharmacoepidemiology and Drug Safety|September 18, 2010
A potential competition bias in the detection of safety signals from spontaneous reporting databasesAntoine Pariente, Marie Didailler, Paul Avillach, et al.
European Journal of Clinical Pharmacology|April 14, 2005
Agreement of expert judgment in causality assessment of adverse drug reactionsYannick Arimone, Bernard Bégaud, Ghada Miremont-Salamé, et al.
Journal of Clinical Epidemiology|February 21, 2006
A new method for assessing drug causation provided agreement with experts' judgmentYannick Arimone, Bernard Bégaud, Ghada Miremont-Salamé, et al.
Therapie|April 5, 2008
[First meeting of the French CEIP (centres d'évaluation et d'information sur la pharmacodépendance). Assessment of the abuse and pharmacodependence potential during drug development]Joëlle Micaleff, Pascale Jolliet, Caroline Victorri-Vigneau, et al.
CNS Drugs|December 25, 2009
Factors associated with serious adverse reactions to cholinesterase inhibitors: a study of spontaneous reportingAntoine Pariente, Dina Joseph-Reinette Sanctussy, Ghada Miremont-Salamé, et al.
Pageof 7

Showing results (31-40 of 67) with videos related to

Sort By:
Pageof 7
Fundamental & Clinical Pharmacology|January 10, 2018
Adverse drug reactions of analgesic medicines: analysis of the Romanian pharmacovigilance databaseIrina Cazacu, Roxana Stroe, Roxana Dondera, et al.
Drug Safety|July 1, 2017
Impact of Medicine Withdrawal on Reporting of Adverse Events Involving Therapeutic Alternatives: A Study from the French Spontaneous Reporting DatabaseCécile Pageot, Julien Bezin, Andy Smith, et al.
Therapie|June 3, 2005
[Antidepressant adverse effects in the elderly: analysis of spontaneous reports in France]Mathilde Daurel-Receveur, Ghada Miremont-Salamé, Annie Fourrier, et al.
Drug Safety|October 8, 2010
Comparison of three methods (consensual expert judgement, algorithmic and probabilistic approaches) of causality assessment of adverse drug reactions: an assessment using reports made to a French pharmacovigilance centreHélène Théophile, Yannick Arimone, Ghada Miremont-Salamé, et al.
British Journal of Clinical Pharmacology|August 23, 2007
Inter-expert agreement of seven criteria in causality assessment of adverse drug reactionsYannick Arimone, Ghada Miremont-Salamé, Françoise Haramburu, et al.
Pharmacoepidemiology and Drug Safety|September 18, 2010
A potential competition bias in the detection of safety signals from spontaneous reporting databasesAntoine Pariente, Marie Didailler, Paul Avillach, et al.
European Journal of Clinical Pharmacology|April 14, 2005
Agreement of expert judgment in causality assessment of adverse drug reactionsYannick Arimone, Bernard Bégaud, Ghada Miremont-Salamé, et al.
Journal of Clinical Epidemiology|February 21, 2006
A new method for assessing drug causation provided agreement with experts' judgmentYannick Arimone, Bernard Bégaud, Ghada Miremont-Salamé, et al.
Therapie|April 5, 2008
[First meeting of the French CEIP (centres d'évaluation et d'information sur la pharmacodépendance). Assessment of the abuse and pharmacodependence potential during drug development]Joëlle Micaleff, Pascale Jolliet, Caroline Victorri-Vigneau, et al.
CNS Drugs|December 25, 2009
Factors associated with serious adverse reactions to cholinesterase inhibitors: a study of spontaneous reportingAntoine Pariente, Dina Joseph-Reinette Sanctussy, Ghada Miremont-Salamé, et al.
Pageof 7